ANAVEX LIFE SCIENCES CORP. Legal Fees
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Legal Fees of $32.82 thousand for the 3-month period ending 2013-12-31, per its 10-Q filed 2014-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2014-02-14
- ANAVEX LIFE SCIENCES CORP. legal fees for the quarter ending 2013-12-31 was $32.82K, a 42.97% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. legal fees for the quarter ending 2013-09-30 was $76.54K, a 69.57% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. legal fees for the quarter ending 2013-06-30 was $27.88K, a 28.88% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. legal fees for the quarter ending 2013-03-31 was $14.35K, a 70.18% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. legal fees for fiscal 2013 was $176.32K, a 23.37% increase from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. legal fees for fiscal 2012 was $142.92K, a 1.64% increase from fiscal 2011.
- ANAVEX LIFE SCIENCES CORP. legal fees for fiscal 2011 was $140.61K, a 18.89% decline from fiscal 2010.
- ANAVEX LIFE SCIENCES CORP. legal fees for fiscal 2010 was $173.37K.
| Period end | Legal Fees 3 month | Legal Fees 6 month | Legal Fees 9 month | Legal Fees 12 month | Legal Fees 89 month | Legal Fees 92 month | Legal Fees 95 month | Legal Fees 98 month | Legal Fees 101 month | Legal Fees 104 month | Legal Fees 107 month | Legal Fees 110 month | Legal Fees 113 month | Legal Fees 116 month | Legal Fees 119 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $32.82K 10-Q · filed 2014-02-14 | $109.36K derived: sum of 2 quarters · filed 2014-02-14 | $137.24K derived: sum of 3 quarters · filed 2014-02-14 | $151.59K derived: sum of 4 quarters · filed 2014-02-14 | $879.16K 10-Q · filed 2014-02-14 | ||||||||||
| 2013-09-30 | $76.54K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $104.42K derived: sum of 2 quarters · filed 2013-12-30 | $118.77K derived: sum of 3 quarters · filed 2013-12-30 | $176.32K 10-K · filed 2013-12-30 | $846.34K 10-K · filed 2013-12-30 | ||||||||||
| 2013-06-30 | $27.88K 10-Q · filed 2013-08-14 | $42.23K derived: sum of 2 quarters · filed 2013-08-14 | $99.77K 10-Q · filed 2013-08-14 | $144.91K derived: sum of 4 quarters · filed 2014-02-14 | $769.80K 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $14.35K 10-Q · filed 2013-05-17 | $71.90K 10-Q · filed 2013-05-17 | $117.04K derived: sum of 3 quarters · filed 2014-02-14 | $138.67K derived: sum of 4 quarters · filed 2014-02-14 | $741.92K 10-Q · filed 2013-05-17 | ||||||||||
| 2012-12-31 | $57.54K 10-Q · filed 2014-02-14 | $102.68K derived: sum of 2 quarters · filed 2014-02-14 | $124.31K derived: sum of 3 quarters · filed 2014-02-14 | $172.46K derived: sum of 4 quarters · filed 2014-02-14 | $727.57K 10-Q · filed 2013-02-14 | ||||||||||
| 2012-09-30 | $45.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $66.77K derived: sum of 2 quarters · filed 2013-12-30 | $114.91K derived: sum of 3 quarters · filed 2013-12-30 | $142.92K 10-K · filed 2013-12-30 | $670.02K 10-K · filed 2012-12-31 | ||||||||||
| 2012-06-30 | $21.63K 10-Q · filed 2013-08-14 | $69.77K derived: sum of 2 quarters · filed 2013-08-14 | $97.78K 10-Q · filed 2013-08-14 | $121.69K derived: sum of 4 quarters · filed 2013-08-14 | $624.88K 10-Q · filed 2012-08-17 | ||||||||||
| 2012-03-31 | $48.14K 10-Q · filed 2013-05-17 | $76.15K 10-Q · filed 2013-05-17 | $100.06K derived: sum of 3 quarters · filed 2013-05-17 | $159.42K derived: sum of 4 quarters · filed 2013-05-17 | $603.26K 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $28.01K 10-Q · filed 2013-02-14 | $51.91K derived: sum of 2 quarters · filed 2013-02-14 | $111.28K derived: sum of 3 quarters · filed 2013-02-14 | $148.88K derived: sum of 4 quarters · filed 2013-02-14 | $555.11K 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | $23.90K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $83.27K derived: sum of 2 quarters · filed 2012-12-31 | $120.87K derived: sum of 3 quarters · filed 2012-12-31 | $140.61K 10-K · filed 2012-12-31 | $527.10K 10-K · filed 2011-12-22 | ||||||||||
| 2011-06-30 | $59.36K 10-Q · filed 2012-08-17 | $96.96K derived: sum of 2 quarters · filed 2012-08-17 | $116.71K 10-Q · filed 2012-08-17 | $189.57K derived: sum of 4 quarters · filed 2012-08-17 | $503.20K 10-Q · filed 2011-08-12 | ||||||||||
| 2011-03-31 | $37.60K 10-Q · filed 2012-05-15 | $57.35K 10-Q · filed 2012-05-15 | $130.21K derived: sum of 3 quarters · filed 2012-05-15 | $185.03K derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||
| 2010-12-31 | $19.75K 10-Q · filed 2012-02-14 | $92.61K derived: sum of 2 quarters · filed 2012-02-14 | $147.43K derived: sum of 3 quarters · filed 2012-02-14 | ||||||||||||
| 2010-09-30 | $72.86K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | $127.69K derived: sum of 2 quarters · filed 2011-12-22 | $173.37K 10-K · filed 2011-12-22 | ||||||||||||
| 2010-06-30 | $54.83K 10-Q · filed 2011-08-12 | $100.51K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |